navoximod

E1249865 UNEXPLORED

Navoximod is an investigational small-molecule inhibitor of the immune checkpoint enzyme IDO1, studied as a cancer immunotherapy agent.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
navoximod canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

NewLink Genetics → developed → navoximod ⓘ